How do I learn more about DMT and its uses?
This list includes ways to learn more about DMT and psychedelics, as well as ways to get actively involved (participate in research).
TED talks on DMT and psychedelics
One of the quickest ways to be brought up to speed on the latest in psychedelic research:
1. The future of psychedelic-assisted psychotherapy (TED talk 2019 by Rick Doblin, PhD, head of MAPS)
“Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising. In this fascinating dive into the science of psychedelics, he explains how drugs like LSD, psilocybin and MDMA affect your brain — and shows how, when paired with psychotherapy, they could change the way we treat PTSD, depression, substance abuse and more.”
2. The science of psilocybin and its use to relieve suffering (TED talk 2016,
“Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.”
- Psychedelic Drug Eases Cancer Patients’ Distress Long Term (U.S. News & World Report) — a good outline of how psychedelics are being used for those with terminal illnesses
- Why Doctors Are Turning to Psychedelics to Treat Depression and Addiction (Men’s Journal) — an interesting look at the collaborations between the medical field and the promising therapeutic benefits of psychedelics
- An Underground Psychedelic Therapist Speaks on Healing Trauma with High Doses of LSD (Psychedelic Times) — one of the best descriptions of the need for integration after a psychedelic experience
- The Way of the Psychonaut (2019): The latest from Stanislav Grof, who pioneered much of the psychedelic research of the 20th century. Other works by Grof include LSD Psychotherapy (1980) and LSD: Doorway to the Numinous: The Groundbreaking Psychedelic Research into Realms of the Human Unconscious (1975)
- DMT: The Spirit Molecule: A Doctor’s Revolutionary Research into the Biology of Near-Death and Mystical Experiences: One of the flagship publications on the subject
- Food of the Gods: The Search for the Original Tree of Knowledge A Radical History of Plants, Drugs, and Human Evolution: Places the role of DMT and its many forms within a wider historical context.
- DMT: The Spirit Molecule: “An investigation into the long-obscured mystery of dimethyltryptamine (DMT), a molecule found in nearly every living organism and considered the most potent psychedelic on Earth.” Can be watched for free on YouTube.
If you want to get involved
If you’re interested in participating in clinical research (either as a participant or a mental health professional), there are two preeminent organizations involved in responsible, monitored psychedelic research:
MAPS is the preeminent, research-based organization focusing on psychedelic research. It is is a 501(c)(3) non-profit research and educational organization dedicated to “developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.”
MAPS’ team includes scientists, lawyers, psychopharmacological experts, “psychonauts” (those committed to psychedelic exploration), and more. Among other things, they are working to get psychedelics like DMT accepted as forms of medicine and therapy for those who can use them the most (those suffering from things like PTSD, anxiety, depression, substance abuse, and more).
MAPS vision is “a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.”
Specifically, they work on:
- “Developing psychedelics and marijuana into prescription medicines
- Training therapists and working to establish a network of treatment centers
- Supporting scientific research into spirituality, creativity, and neuroscience
- Educating the public honestly about the risks and benefits of psychedelics and marijuana.”
MAPS is actively seeking research participants in a number of clinical trials involving MDMA,
According to Paul B. Rothman, M.D., and CEO of Johns Hopkins Medicine, “Johns Hopkins is deeply committed to exploring innovative treatments for our patients. Our scientists have shown that psychedelics have real potential as medicine, and this new center will help us explore that potential.”
Researchers at the Center for Psychedelic and Consciousness Research “focus on how psychedelics affect behavior, mood, cognition, brain function, and biological markers of health. Upcoming studies will determine the effectiveness of psilocybin as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa and alcohol use in people with major depression. The researchers hope to create precision medicine treatments tailored to the specific needs of individual patients.”
The Third Wave is an educational site and center for grounded information and more. As an organization, they are committed to helping humanity with “integrating intentional, measured, and responsible psychedelic use into our everyday lives.”
The Third Wave asserts that “[t]he first wave of psychedelics involved global indigenous use for thousands of years, the second wave was the counterculture movement of the 1960s, and today is the third wave of psychedelics.”
Their vision and mission:
“It is an era not for ‘dropping-out’ and rebelling against society, but for integrating psychedelics into our mainstream culture; an era invigorated by the tremendous upside of responsible psychedelic use rather than paralyzed by misguided fear of their possible negative repercussions.
Here at The Third Wave, we plan to contribute to this new era by providing reliable, well-researched information about psychedelics; incubating online and in-person psychedelic community; and working within mainstream culture through constructive conversations with thought-leaders across all major fields and disciplines.
In short, we’re here to help change the hearts and minds of people everywhere.”